darunavir has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Armentano, MF; Bisaccia, F; Chiummiento, L; D'Orsi, R; Funicello, M; Laurenzana, I; Lupattelli, P; Miglionico, R; Monné, M; Nigro, I; Rinaldi, R; Sgambato, A | 1 |
1 other study(ies) available for darunavir and Liver Neoplasms
Article | Year |
---|---|
Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2.
Topics: Apoptosis; Autophagy; Binding Sites; Carcinoma, Hepatocellular; Cell Shape; Cell Survival; Darunavir; Hep G2 Cells; HIV-1; Humans; Liver Neoplasms; Molecular Docking Simulation; Protease Inhibitors; Proteasome Endopeptidase Complex; Unfolded Protein Response | 2021 |